Sign in

NCT07620795Not yet recruiting

Effect of Web-Based Education on Attitudes and Beliefs About HPV Testing

THE EFFECT OF WEB-BASED EDUCATION GIVEN TO WOMEN ON THEIR ATTITUDES AND BELIEFS ABOUT HPV TESTING

Source: ClinicalTrials.gov · Last updated 22 Sept 2026

Brief summary (registry, in English)

Cervical cancer is a highly preventable public health issue that significantly impacts women's quality of life. Although effective screening programs such as Human Papilloma Virus (HPV) testing and Pap-smears are widely available, women's participation in these early detection services often remains limited. The primary barriers to screening attendance include insufficient education, lack of information, negative beliefs, psychosocial or cultural factors, and misconceptions regarding gynecological examinations. To improve screening uptake, health interventions must focus not only on increasing knowledge but also on promoting correct beliefs and positive attitudes toward testing. Web-based health education serves as an effective method to overcome barriers such as cost, transportation difficulties, and geographical limitations, allowing wider access to healthcare guidance. This study aims to evaluate the effects of a specialized web-based educational intervention on women's attitudes and beliefs regarding the HPV test. The research is designed as a randomized controlled trial with a pre-test and post-test design. Participants will be assigned to either an intervention group or a control group. The intervention group will receive structured health education through a dedicated web platform, while the control group will receive routine standard follow-up. Data will be gathered using a specific attitude and belief scale before and after the application to measure the intervention's impact.

Status (registry)
Not yet recruiting
Study type
Interventional
Enrollment
120 (estimated)
First submitted
20 May 2026
Start date
1 Nov 2026
Primary completion date
1 Jan 2027
Lead sponsor
Sakarya University
NCT number
NCT07620795

What you commit to

  • Study type: Interventional
  • Planned participants: 120
  • From 1 Nov 2026 to the primary completion date, 1 Jan 2027
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to respond to or complete the data collection tools

Other

  • Withdrawing from the study voluntarily at any stage
  • Failing to watch the mandatory educational videos on the platform
  • Submitting incomplete or incorrect responses to the data collection tools
  • Lacking active internet access or proper web browser usage skills
    • Criteria for Study Discontinuation / Drop-out:
  • Participant's request to withdraw from the study
  • Not using or logging into the web application for more than 2 consecutive weeks during the study period

Who the study is looking for

  • Having no prior clinical diagnosis of cervical cancer
  • Being between 18 and 60 years of age
  • Having active access to the internet
  • Being literate at a level sufficient to read and understand the questionnaire forms
  • Being capable of effectively navigating and using a web browser
  • Being registered as a patient at Sakarya Akyazı No. 3 Family Health Center
  • Volunteering to participate in the study and providing informed consent

Age in the registry: 18 years to 60 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.